HealthOctober 27, 2025

Future of life sciences: Using clinical insights to drive business goals

Three scientists in a lab working on experiments
Life sciences organizations are looking ahead and leveraging evidence-based insights and pricing data to help them plan around market uncertainty.

The past year has been a cautious one for life sciences organizations, marked by increases in market and regulatory uncertainty combined with pressure to improve portfolio performance. With organizational changes looming at the FDA and other U.S. governmental agencies and ongoing uncertainty about tariff policies, companies have been challenged to determine strategies designed around flexibility.

As life sciences organizations look ahead to focus on optimizing various business practices and – like so many other industries – implement AI and machine learning to drive efficiency, there will be an increasing need for evidence-based clinical data to support due diligence, global compliance, and unified launch strategies grounded in industry needs.

Current state: Life sciences explores insight-driven business decisions

Data is the new currency for life sciences organizations. However, the sheer volume of available data has increased the complexity of acquiring, synthesizing, and acting upon it.

Sources like drug data, clinical evidence, internet usage, clinical trial data, administrative records, and population health data complicate the life sciences data landscape. Each source introduces new challenges and opportunities.

To properly navigate opportunities and drive better business decisions, life sciences leaders have been seeking fast access to reliable evidence and research for targeted use cases and learning how to broaden their understanding and usage of data opportunities, including:

  • Leveraging clinical insights.
  • Driving strategy with data and analytics.
  • Centralizing resources.

Leveraging clinical insights in drug development

Incorporating clinical insights into life sciences workflows can help enrich the drug development process by helping teams better understand the clinician journey and better discern market needs and existing gaps. These insights are particularly valuable for R&D and market access teams, which often face challenges in these areas. With access to real-world data to unlock value opportunities and vital evidence-based insights on clinical decision-making and pricing strategies, life sciences companies can implement this knowledge across the product lifecycle, from development and launch strategy to supporting post-launch communications.

Driving strategy with data and analytics

Data analytics allows life sciences companies to distill large and disparate datasets into actionable insights on clinical trends, market behavior, and patient outcomes. Life sciences organizations can then apply those insights to enhancing research efficiency, streamlining trial planning, and informing competitive market strategy. They can also drive more consistent and efficient operations when data is aggregated and aligned across the organization.

Centralizing resources across teams

Fragmented systems and siloed teams have long been the norm for life sciences organizations. Clinical research, regulatory compliance, marketing, and other departments often rely on isolated databases and processes, creating inefficiencies and redundancies.

Centralized resources bridge these gaps, enabling:

  • Improved workflow efficiencies.
  • Cost reduction.
  • Enhanced collaboration.
  • Better overall outcomes.

Looking ahead: Focus on pricing strategies, acquisitions

Following a year when spending was conservative, the governmental landscape was uncertain, and hiring was slow, life sciences companies are beginning to refocus on optimizing data resources to pursue potential advantages. That can include:

  • Competitive pricing strategies: Monitoring competition, evaluating alternative therapies, and analyzing gaps in the market and generic market potential.
  • Strategic acquisitions: When developing novel substances is a time-consuming and expensive proposition, many organizations are prioritizing tracking successful ventures to determine opportunities to grow their portfolios.

To unlock efficiency, remain competitive, and create business operations that sustain growth, life sciences organizations need a solutions partner that is future-facing and can help them capitalize on opportunities to streamline processes and deepen research capabilities with trusted, evidence-based content.

Price Rx: Deeper drug pricing analysis

When life sciences companies have a product in market, they count on Medi-Span® Price Rx® to help them “keep tabs” on competition.

Price Rx is considered the standard in the industry for extensive, timely, and trusted drug information and drug pricing data on more than 180,000 active and inactive products after decades of having nurtured relationships with pharmaceutical manufacturers and pharmacy benefit managers (PBMs). That allows its expert editorial team to facilitate exchange of new and updated price information and deliver updates with unmatched speed. At the same time, Price Rx maintains a rigorous editorial policy that strives to keep information unbiased, publishing a wide variety of pricing data elements obtained from diverse sources and developed through a respected, independent editorial team.

Using the Medi-Span proprietary Generic Product Identifier – or GPI – hierarchical drug coding structure, Price Rx empowers life sciences organizations to perform highly flexible and granular classification of drugs, supporting:

  • Competitive analysis on product pricing and usage.
  • Comparing alternative therapies.
  • Brand probability determinations – proprietary calculator gives a percentage score of how likely a product is to be a brand versus a generic.

Finding new business opportunity with UpToDate

UpToDate® clinical intelligence supports literature searches and medical research to determine where there could be R&D opportunities.

UpToDate is trusted by more than 3 million users worldwide, including 90% of healthcare professionals in the U.S. who use it every day. It is accessed more than 60 million times a month by HCPs to support or confirm clinical decisions. Life sciences experts note that UpToDate gives them a lens into what practicing providers are seeing and recommending. That’s why it also proves useful for:

  • Internal training for business development.
  • Medical affairs, including educating key opinion leaders and informing conversations with industry colleagues.
  • Supporting and informing clinical trials.

Knowing that the content is rigorously reviewed by more than 7,400 practicing clinician and expert authors, editors, and peer reviewers following strict editorial processes designed to keep content balanced, unbiased, and based in evidence creates confidence when teams communicate or share literature with doctors that they will recognize the source as familiar, trusted, and authoritative.

Both UpToDate and Price Rx support strengthening clinical insights and competitive analysis to drive future initiatives and help life sciences organizations be prepared for the next steps in development, acquisition, positioning, and outreach.

Speak with a specialist to request a demo or learn more about evidence-based solutions for life sciences.

Speak With An Expert
Speak With An Expert
Solutions
UpToDate for Life Sciences
Align teams and drive business decisions and drug development with UpToDate clinical insights and Medi-Span drug pricing data and analysis.
Learn More

Related Insights

  • Podcast
    Health
    October 27, 2025

    Ignite active learning in your classroom

    Boost engagement, creativity, and teaching strategies for meaningful learning outcomes with Dr. Virginia Wangerin and Dr. Sue Hendricks.
    Learn More
  • Article
    Health
    October 27, 2025

    The critical role of value sets in data-driven healthcare: Challenges and solutions

    Learn the difference between intensional and extensional value sets, the challenges of managing them, and strategies to maintain accurate, standardized healthcare data.
    Learn More
  • Article
    Health
    October 27, 2025

    Pharmacies must deliver closed-loop training systems for sterile compounding

    Closed-loop systems for training empower compounding pharmacies to strengthen compliance, improve patient safety, and streamline operations.
    Learn More
  • Article
    Health
    Updated October 24, 2025

    How an educational EHR improves patient outcomes on the job

    EHR iDiscover how academic EHRs improve patient outcomes by training nursing students in proper documentation, reducing medical errors, and boosting practice readiness.
    Learn More
Back To Top